Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death—Results from the Norwegian Prostate Cancer Consortium
Johan Bjerner, Jan Oldenburg(Akershus University Hospital), Oluf Dimitri Røe(Norwegian University of Science and Technology), Jochen Walz(Institut Paoli-Calmettes), Andrew J. Vickers(Memorial Sloan Kettering Cancer Center), Ola Bratt(Sahlgrenska University Hospital), Kirsti Aas(University of Oslo), Hans Lilja(Memorial Sloan Kettering Cancer Center), Andreas Stensvold(Østfold Hospital Trust), Rune Kvåle(Norwegian Institute of Public Health), Sophie D. Fosså(Oslo University Hospital), Sigrid Carlsson(Memorial Sloan Kettering Cancer Center), Christoph Müller(Sørlandet Sykehus), Stig Müller(Akershus University Hospital), Owen Thomas(Akershus University Hospital), Peter C. Albertsen(UConn Health)
Cited by 13
Related Papers
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
|Clinical Chemistry|2008|1.1k
Acupuncture for Chronic Pain
|Archives of Internal Medicine|2012|976
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975